BR112020000902B1 - Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura - Google Patents

Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura Download PDF

Info

Publication number
BR112020000902B1
BR112020000902B1 BR112020000902-4A BR112020000902A BR112020000902B1 BR 112020000902 B1 BR112020000902 B1 BR 112020000902B1 BR 112020000902 A BR112020000902 A BR 112020000902A BR 112020000902 B1 BR112020000902 B1 BR 112020000902B1
Authority
BR
Brazil
Prior art keywords
composition
iron
salt
vitamin
lecithin
Prior art date
Application number
BR112020000902-4A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112020000902A2 (pt
Inventor
Andrea Lacorte
Germano Tarantino
Elisa BRILLI
Original Assignee
Pharmanutra S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S.P.A. filed Critical Pharmanutra S.P.A.
Publication of BR112020000902A2 publication Critical patent/BR112020000902A2/pt
Publication of BR112020000902B1 publication Critical patent/BR112020000902B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112020000902-4A 2017-07-26 2018-07-26 Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura BR112020000902B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT102017000085412 2017-07-26
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Publications (2)

Publication Number Publication Date
BR112020000902A2 BR112020000902A2 (pt) 2020-07-21
BR112020000902B1 true BR112020000902B1 (pt) 2024-03-12

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020000902-4A BR112020000902B1 (pt) 2017-07-26 2018-07-26 Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura

Country Status (19)

Country Link
US (1) US20200206157A1 (https=)
EP (1) EP3657963A1 (https=)
JP (2) JP2020528888A (https=)
KR (1) KR20200032691A (https=)
CN (1) CN111031813A (https=)
BR (1) BR112020000902B1 (https=)
CA (1) CA3070659A1 (https=)
CL (1) CL2020000170A1 (https=)
CO (1) CO2020000526A2 (https=)
EA (1) EA202090069A1 (https=)
IL (1) IL272138B2 (https=)
IT (1) IT201700085412A1 (https=)
JO (1) JOP20200012A1 (https=)
MA (1) MA49794A (https=)
MX (1) MX2020000806A (https=)
PE (1) PE20200794A1 (https=)
PH (1) PH12020550031A1 (https=)
WO (1) WO2019021232A1 (https=)
ZA (1) ZA202000461B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237054A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
MX2020013302A (es) 2018-06-08 2021-05-12 Epizon Pharma Inc Métodos y composiciones para prevenir o tratar calcificación de tejido.
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
JP2025518284A (ja) 2022-05-31 2025-06-12 リージョン スイダンマーク 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
WO1996039053A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
CN101094681A (zh) * 2003-10-28 2007-12-26 爱默蕾大学 透析液及其相关方法和系统
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
BRPI0620425B8 (pt) * 2005-12-23 2021-06-22 Gupta Ajay composição para nutrição parenteral, método para preparar a mesma, uso, e, kit
EP3066923B1 (en) * 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
CN102159222B (zh) * 2008-12-25 2014-08-06 I.B.E.有限会社 生物活性剂，药物，化妆品，保鲜剂，以及植物以及动物的发育促进剂
RU2606767C2 (ru) * 2011-05-20 2017-01-10 Фрисланд Брандз Б.В. Композиция, содержащая витамин k2
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
EP3258924A2 (en) * 2015-02-20 2017-12-27 VitaK B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Also Published As

Publication number Publication date
WO2019021232A1 (en) 2019-01-31
JOP20200012A1 (ar) 2020-01-26
JP2023090869A (ja) 2023-06-29
EP3657963A1 (en) 2020-06-03
IL272138B2 (en) 2023-09-01
CA3070659A1 (en) 2019-01-31
MX2020000806A (es) 2020-08-17
ZA202000461B (en) 2021-03-31
BR112020000902A2 (pt) 2020-07-21
JP2020528888A (ja) 2020-10-01
CO2020000526A2 (es) 2020-02-18
PE20200794A1 (es) 2020-08-10
MA49794A (fr) 2020-06-03
CN111031813A (zh) 2020-04-17
IL272138B1 (en) 2023-05-01
KR20200032691A (ko) 2020-03-26
IT201700085412A1 (it) 2019-01-26
US20200206157A1 (en) 2020-07-02
IL272138A (en) 2020-03-31
PH12020550031A1 (en) 2021-02-08
EA202090069A1 (ru) 2020-04-10
CL2020000170A1 (es) 2020-10-30

Similar Documents

Publication Publication Date Title
BR112020000902B1 (pt) Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura
Kapoor et al. Coenzyme Q10-a novel molecule
ES2260293T3 (es) Composicion que comprende acido hidroxicitrico y garcinol para reduccion de peso.
BR122022015143B1 (pt) Método para preparar uma composição sólida à base de ferro
TW201402130A (zh) 包含蘿蔔硫素之組成物或包含一種蘿蔔硫素前驅物及鎂之組成物
JP2024517556A (ja) コエンザイムｑ１０含有液状補助飼料組成物
US20230019690A1 (en) Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
CN100430046C (zh) 用于治疗与年龄相关的疾病的组合物与方法
HU227182B1 (en) Lecitin-ascorbic acid combination
EA046793B1 (ru) Применение композиции (варианты) для профилактического или терапевтического лечения кальцификации сосудов
HK40018499A (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
US20080233182A1 (en) Organic compounds
US20250275982A1 (en) Solid form formulation comprising chromium or copper or a vitamin, compositions and uses thereof
US20260053849A1 (en) New iron and acacia gum oral compositions, process for their preparation and their use in iron deficiency conditions
WO2012119049A2 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
JP4896531B2 (ja) 血中ＣｏＱ１０量を増加させる医薬組成物
JP2008044894A (ja) メタボリックシンドローム改善剤
BR112017026291B1 (pt) Dispersões sólidas, formulações farmacêuticas ou nutracêuticas e método para preparar uma dispersão sólida

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/07/2018, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 7A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2841 DE 17-06-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.